Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Sigmaker Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of chemical drugs and active pharmaceutical ingredients (APIs). The company operates a comprehensive production base in Chengdu, focusing on therapeutic areas such as cardiovascular health, digestive system disorders, and anti-infectives. Sigmaker provides both finished dosage forms and contract manufacturing services (CMO/CDMO) to domestic and international partners. Their facilities are designed to meet GMP standards, supporting the large-scale production of small molecule therapeutics. The company is recognized for its commitment to quality and its role in providing essential generic medications to the healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Sigmaker.